InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-13.7%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by COHEN MARC A, Director. Insider active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 8 filings have been logged. Activity tracked since 14 June 2021. The latest transaction was disclosed on 4 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
657 shares@ US$31.580.0099% mcap17.1% of flowCommon StockSEC:0001209191-22-003503:0
657 shares@ US$31.5817.1% of flowCommon StockSEC:0001209191-22-003503
461 shares@ US$44.990.0096% mcap16.6% of flowCommon StockSEC:0001209191-21-059522:0
461 shares@ US$44.9916.6% of flowCommon StockSEC:0001209191-21-059522
522 shares@ US$39.720.0095% mcap16.3% of flowCommon StockSEC:0001209191-21-045807:0
522 shares@ US$39.7216.3% of flowCommon StockSEC:0001209191-21-045807
92,817 shares0Common StockSEC:0001209191-21-040278
92,817 shares0Common StockSEC:0001209191-21-040278:0
8 of 8 declarations
About COHEN MARC A
Marc A. Cohen is a Board Member at C4 Therapeutics, Inc. He plays a key role in the governance and strategy of the company. Cohen brings expertise in the biopharmaceutical sector, which is essential for the development of C4 Therapeutics.
